SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa

Bibliographic Details
Title: SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa
Authors: Jackie Kleynhans, Stefano Tempia, Nicole Wolter, Anne von Gottberg, Jinal N. Bhiman, Amelia Buys, Jocelyn Moyes, Meredith L. McMorrow, Kathleen Kahn, F. Xavier Gómez-Olivé, Stephen Tollman, Neil A. Martinson, Floidy Wafawanaka, Limakatso Lebina, Jacques D. du Toit, Waasila Jassat, Mzimasi Neti, Marieke Brauer, Cheryl Cohen
Source: Emerging Infectious Diseases, Vol 28, Iss 5, Pp 1055-1058 (2022)
Publisher Information: Centers for Disease Control and Prevention, 2022.
Publication Year: 2022
Collection: LCC:Medicine
LCC:Infectious and parasitic diseases
Subject Terms: COVID-19, coronavirus disease, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, Medicine, Infectious and parasitic diseases, RC109-216
More Details: By November 2021, after the third wave of severe acute respiratory syndrome coronavirus 2 infections in South Africa, seroprevalence was 60% in a rural community and 70% in an urban community. High seroprevalence before the Omicron variant emerged may have contributed to reduced illness severity observed in the fourth wave.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1080-6040
1080-6059
Relation: https://wwwnc.cdc.gov/eid/article/28/5/22-0278_article; https://doaj.org/toc/1080-6040; https://doaj.org/toc/1080-6059
DOI: 10.3201/eid2805.220278
Access URL: https://doaj.org/article/d47083157aa74d098d978a5ba9d51fe3
Accession Number: edsdoj.47083157aa74d098d978a5ba9d51fe3
Database: Directory of Open Access Journals
More Details
ISSN:10806040
10806059
DOI:10.3201/eid2805.220278
Published in:Emerging Infectious Diseases
Language:English